Related references
Note: Only part of the references are listed.Host controls of HIV broadly neutralizing antibody development
Garnett Kelsoe et al.
IMMUNOLOGICAL REVIEWS (2017)
Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies
Penny L. Moore et al.
IMMUNOLOGICAL REVIEWS (2017)
Genetic and structural analyses of affinity maturation in the humoral response to HIV-1
Thomas B. Kepler et al.
IMMUNOLOGICAL REVIEWS (2017)
Polyvalent vaccine approaches to combat HIV-1 diversity
Bette Korber et al.
IMMUNOLOGICAL REVIEWS (2017)
Survivors Remorse: antibody-mediated protection against HIV-1
George K. Lewis et al.
IMMUNOLOGICAL REVIEWS (2017)
Use of broadly neutralizing antibodies for HIV-1 prevention
Amarendra Pegu et al.
IMMUNOLOGICAL REVIEWS (2017)
Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention
Jacqueline M. Brady et al.
IMMUNOLOGICAL REVIEWS (2017)
Evolution of B cell analysis and Env trimer redesign
Gunilla B. Karlsson Hedestam et al.
IMMUNOLOGICAL REVIEWS (2017)
Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies
Laurent Verkoczy et al.
IMMUNOLOGICAL REVIEWS (2017)
HIV antibodies for treatment of HIV infection
David M. Margolis et al.
IMMUNOLOGICAL REVIEWS (2017)
The HIV-1 envelope glycoprotein structure: nailing down a moving target
Andrew B. Ward et al.
IMMUNOLOGICAL REVIEWS (2017)
Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1
Peter D. Kwong et al.
IMMUNOLOGICAL REVIEWS (2017)
Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
Persephone Borrow et al.
IMMUNOLOGICAL REVIEWS (2017)
Anti-retroviral antibody FcR-mediated effector functions
Stylianos Bournazos et al.
IMMUNOLOGICAL REVIEWS (2017)
Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development
Mattia Bonsignori et al.
IMMUNOLOGICAL REVIEWS (2017)
Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem
Colin Havenar-Daughton et al.
IMMUNOLOGICAL REVIEWS (2017)
Germline-targeting immunogens
Leonidas Stamatatos et al.
IMMUNOLOGICAL REVIEWS (2017)
Complex immune correlates of protection in HIV-1 vaccine efficacy trials
Georgia D. Tomaras et al.
IMMUNOLOGICAL REVIEWS (2017)
Systems serology for evaluation of HIV vaccine trials
Margaret E. Ackerman et al.
IMMUNOLOGICAL REVIEWS (2017)
Native-like Env trimers as a platform for HIV-1 vaccine design
Rogier W. Sanders et al.
IMMUNOLOGICAL REVIEWS (2017)
Identification and specificity of broadly neutralizing antibodies against HIV
Laura E. McCoy et al.
IMMUNOLOGICAL REVIEWS (2017)
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
Bryan Briney et al.
CELL (2016)
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
Amelia Escolano et al.
CELL (2016)
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires
Ming Tian et al.
CELL (2016)
HIV-Host Interactions: Implications for Vaccine Design
Barton F. Haynes et al.
CELL HOST & MICROBE (2016)
An HIV Vaccine Mapping Uncharted Territory
Anthony S. Fauci
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogene
Joseph G. Jardine et al.
SCIENCE (2016)
Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies
M. Anthony Moody et al.
SCIENCE IMMUNOLOGY (2016)
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
Pia Dosenovic et al.
CELL (2015)
Antibody responses to envelope glycoproteins in HIV-1 infection
Dennis R. Burton et al.
NATURE IMMUNOLOGY (2015)
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
Joseph G. Jardine et al.
SCIENCE (2015)
Immune correlates of vaccine protection against HIV-1 acquisition
Lawrence Corey et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
Peter Hraber et al.
AIDS (2014)
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1
Mattia Bonsignori et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria-Rose et al.
NATURE (2014)
Host Controls of HIV Neutralizing Antibodies
Barton F. Haynes et al.
SCIENCE (2014)
HIV-1 neutralizing antibodies: understanding nature's pathways
John R. Mascola et al.
IMMUNOLOGICAL REVIEWS (2013)
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao et al.
NATURE (2013)
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Joseph Jardine et al.
SCIENCE (2013)
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
Sam Hoot et al.
PLOS PATHOGENS (2013)
B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study
Barton F. Haynes et al.
NATURE BIOTECHNOLOGY (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2h study
Glenda E. Gray et al.
LANCET INFECTIOUS DISEASES (2011)
Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV-1 gp120 Vaccine
Peter Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
Xiaodong Xiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
Punnee Pitisuttithum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies
BF Haynes et al.
SCIENCE (2005)
Share Paper
